Eden Research Share Discussion Threads

[brucie5] 16/3/2019 17:47

Digital chuminess? I'd have to think about that.

[supersonico] 16/3/2019 16:02

I'm wondering mostly these days if Sipcams Sustaine collaborator is likely to be Eastman given the relationships that have been built over the last few years. Some key players in both companies seem to be digitally chummy.

[brucie5] 16/3/2019 15:41

Investing, having watched the demise of Redt on another board, which was a company for which I had high hopes, not least for its environmental impact, I can well understand current diffidence around long disappointing Aim hopefuls, without current of historic profits. I would like to see lykele's buy in for starters, as he seems to have signaled he would.

I am still strongly invested here, and allowing myself for time being, to overlook aspects of this, including the seemingly inscrutable delay on consumer products out of TT, and the opaqueness around Bayer's progress. Because of the involvement of Eastman and Sipcam, I remain hopeful.

But this is no climate for cash calls, nor the vaguest suspicion that one become necessary.

[investingisatrickygame] 16/3/2019 13:44

What will motivate Eden's share price today?


After acknowledgement that the Eastman deal is the biggest in the Company's history, what will Eden do to align price to value?

It is such an important metric for Eden to address for a host of reasons and now more than ever, feels like the right time to do so.

[supersonico] 16/3/2019 12:31

2013 Was an interesting year for biocontrol on both the Bayer and Eden Timeline.

[supersonico] 16/3/2019 09:18

While the International Agricultural Show opens its doors on February 22, the research today takes a new step to build an agriculture more respectful of the environment and human health.



Frédérique Vidal, Minister of Higher Education, Research and Innovation and Guillaume Boudy, Secretary General for Investment, were presented by Philippe Mauguin, Chief Executive Officer of INRA, the report defining the guidelines the priority research program entitled "Cultivate and Protect Otherwise". This program, the principle of which was announced in July 2018, will receive 30 million euros from the 3rd Future Investment Program. The report proposes a clear and ambitious roadmap for the scientific community to develop with the actors of the agricultural world new alternative practices to the use of phytosanitary products.

The scientific knowledge on the cultivated plants, on their interactions with the soil, with their weeds, with their aggressors: insects, fungi, viruses ... will be deepened and mobilized in order to use the services of the biodiversity to stimulate the mechanisms of natural defenses at the level of the plant, the plot, the landscape and to lead the crops.

To complete these highly innovative research actions, the report recommends the establishment of structuring tools. It is envisaged, for example, to couple biological sensors and artificial intelligence to monitor in real time the appearance and development of pests and thus help crop management. To accompany the transition to pesticide-free agricultural practices, reference infrastructures will also be developed or created to best characterize the exposure of agricultural workers and the population and help to ensure the safety of substances that could be substituted for phytosanitary issues of greatest concern.

The Ministry of Higher Education, Research and Innovation, the General Secretariat for Investments and the National Research Agency will now work with INRA and public and private research actors to identify, define and sequencing the call for projects to be launched in June 2019.

The scientific steering of the program will be provided by INRA on behalf of the entire French scientific community and interact with it, relying on an international scientific committee. The program's actions will reinforce national initiatives for research and applied research aimed at reducing the use of pesticides, particularly the dedicated calls for projects of the National Research Agency and the Ecophyto 2+ plan carried out by the Ministries of the Ecological Transition and Solidarity, Solidarities and Health, Higher Education, Research and Innovation, Agriculture and Food and European research programming initiatives, including those to be launched in the Horizon-Europe framework program.

[supersonico] 16/3/2019 09:07

INTEGRATED BIOLOGICAL PROTECTION AND BIOCONTROL: principles and importance in plant pest and disease management



P8
Biocontrol products containing molecules
antimicrobial plants.
Essential oils (terpene oils) contain
a variety of molecules with a high potential for
cal. Thus eugenol, geraniol, are approved
thymol or sweet orange essential oil
rich in limonene against gray rots of
mildew and powdery mildew (ACTA Biocontrol Index 2018).

CONCLUSION
There are effective biocontrol solutions that can
replacing synthetic pesticides. The
more often these solutions fully express their
activity potential when used in
an integrated biological protection approach.
The use of biocontrol is growing. The
dissemination and optimization of the activity of these solutions
biocontrol will have to go through an effort to understand
their mode of action and training in the use of
Readers and advocates.
Moreover, these solutions are aging and
solutions displaying original modes of action
have arrived on the market in the last ten years.
Research efforts are therefore needed to
to elucidate the complex modes of action of the solutions
developing and to ensure the sustainability of
their usage.
To conclude, it is necessary to develop
integrated multidisciplinary research approaches
and holistic in order to develop innovative solutions
by their modes of action while optimizing
their modes of application and securing the economic model.
nomic allowing their marketing.
………

[supersonico] 15/3/2019 13:13

The Ramazzini Institute 13-week pilot study glyphosate-based herbicides administered at human-equivalent dose to Sprague Dawley rats: effects on development and endocrine system



Conclusions.

The present pilot study demonstrate that GBHs exposure, from prenatal period to adulthood, induced endocrine effects and altered reproductive developmental parameters in male and female SD rats. In particular, it was associated with androgen-like effects, including a statistically significant increase of AGDs in both males and females, delay of FE and increased testosterone in female.

[chrischas] 14/3/2019 17:21

Disagree I’ve read all that too.I don’t believe in being a back seat driver.

[supersonico] 14/3/2019 15:14

Chrischas,

Antoine Meyer president of Sumi-agro as I understand it is also the president of the French arm of the IBMA. That and the election of Sylvia Plak of Sumitomo as President of the IBMA along with Edens Sumitomo connection via Sipcam/ Sumiagro and Valent Bioscience make all these networks interesting to observe, to me at least.

I think we should be well represented.

[chrischas] 14/3/2019 13:48

I have read about IBMA before and I cannot for the life me understand why Eden is not there. Apart from putting your head above the parapet ,being a member would be be a way of teaching yourselves how to position your company and also you would gain so much about the market.
I could go on and on about ivory towers .

[investingisatrickygame] 14/3/2019 13:37

Who here is from Powerscourt?

A step-change is needed.

It's like watching paint dry.

No material interest in investing in eden at all. Totally illiquid!

[supersonico] 14/3/2019 12:55

Given the recent flurry of Media, I'm optimistically hoping we'll see reported progress on some aspects of the commercialisation that has been in the pipeline over the last 4-6 years on various fronts.

Of course the most telling indicator of news to come has been and will be the number of Powerscourt bods etal that turn up here to ensure we all keep on carrot.

[littlealbatross2] 14/3/2019 11:37

Final Results due next week 20/03/2019. I wonder what will/won't be revealed.

[supersonico] 14/3/2019 08:01

Sumitomo..Direction of Travel..News

The innovation of Sumitomo Chemical Italia is biorational!

ROMEO, the inducer of resistance suggested in low dose copper strategies

The recent European proposal to reduce the limits of use of copper EC Regulation 2018/1981 (maximum 28 kg in 7 years of copper metal per hectare) spurs farmers, technicians and researchers in the sector to try and use new, more innovative defense strategies environmentally friendly.

After years of studies and field trials with qualified research centers, last April was registered: ROMEO®, the inductor of biological and multitarget resistance.
Cerevisane substance of which Romeo is composed, is an inert fraction deriving from the yeast Saccharomyces cerevisiae (strain LAS117 non GMO) recognized by the EU as a Low Risk Substance.

Romeo® acts preventively by contact and, mimicking the action of a pathogenic fungus, is perceived by the treated plant as an imminent danger. The plant, feeling threatened (even in the absence of a real infection), activates its defenses extremely quickly, thus ensuring an effective immunological response.
It is important to underline that Romeo® is the only inductor of resistance recorded both on oidium and on downy mildew and botrytis, the main pathogenic fungi of the vine and that:
It improves the activity of copper and allows a significant reduction
In strategy with sulfur it allows to optimize its effectiveness and to reduce its use in the field.

It guarantees a biological antibotritic defense in the final stages of the cultural cycle
Romeo®, in essence, anticipates, stimulates and maximizes the natural reaction that the plant would have in the presence of a fungal attack. The natural responses that the plant readily provides in 12-48 hours, favor an excellent endogenous defense, active for 7-10 days.
Due to its characteristics, Romeo® is an ideal partner for all defense solutions, both in integrated agriculture and in organic farming.





…………………..



Biocontrols Conference & Expo Highlights:

Real-world success stories in integrating biocontrols with conventional, organic, and integrated pest management programs
Practical knowledge of how to select, purchase, apply, and measure the effectiveness of biocontrol products in a range of actual growing environments
Regulatory and market developments that are encouraging or requiring more use of biocontrols
Latest products, techniques, and technological developments in biocontrols for improved operations and profitability
A lively tradeshow floor featuring many of the leading biocontrol suppliers in the country
For PCAs and CCAs, the opportunity to earn Continuing Education Units (CEUs)

[supersonico] 13/3/2019 10:09

Sylvia Plak, from Sumitomo Chemical Agro Europe/Valent BioSciences

IBMA@IBMAgl

IBMA Global well represented in @IBMAFrance AGM with its new President S.Plak (Sumitomo) and its Treasurer K.Grosbeau (@ELEPHANTVERT) with 97% of French Members present to discuss, vote and work together for the #biocontrol industry growth. #biocontrole #sustainableagriculture.
……….

Election for board positions

Continuing with governance of our association: before the summer, candidates were asked to step forward for the President and Treasurer positions as, according to the statutes, the current officers cannot continue after a six year period served. For each position only one candidate was nominated despite various activities over the summer period behind the scenes to attract more candidates. A vote was held during the AGM and both candidates were elected for the respective positions. Our new president in 2019 will be Sylvia Plak, from Sumitomo Chemical Agro Europe/Valent BioSciences, and our new treasurer will be Karine Grosbeau, from Elephant Vert.





-Lead, supervise and manage the Regulatory Affairs and Product Development in EMEA.
-Generate and implement the development plan from early stage phase to full life cycle.
-Predict the impact of regulatory changes on the marketing plan in EU and predict the impact of these changes on product registrability and marketability.
-Recommend and implement development and registration strategies in order to optimize the development of the business in the territory.
-Plan and implement development and registration programs in order to rapidly submit high quality files and minimize delays during official review.
-Actor in the general management of Sumitomo
-Rorganised teams, project and workflow/load.
-Developped stewardship activities.
-Manage 24 persons.



President - Sylvia Plak .

Sylvia is Registration and Regulatory Affairs Director at Sumitomo Chemical Agro Europe SAS, a position she has held since 2009. She has previously also combined this with the role of Development Director. As she leads activities for both conventional and biocontrol plant protection products, Sylvia has gained a great deal of experience developing and registering all types of technologies. She is also member of the company Management Committee and is therefore deeply involved in other facets of company strategy and operations.

Sylvia obtained a Degree as an agricultural engineer at the University of Agricultural Science in Gembloux (Belgium) and is fluent in French, Dutch and English. During her career, she has been active in industry associations at national, European and global level, representing industry for 30 years. Linked to the hybrid product range she is managing in EMEA Region, she is currently member of ECPA’s Regulatory Policy Team. Due to the growing importance of the biocontrol products, Sumitomo Chemical strongly supports Sylvia in this presidential position.
………..

Antimicrobial resistance shows no signs of slowing down.

ECDC/EFSA report “rings alarm bells”, says EU Commissioner.

Data released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.

Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, said: “The report released today should ring – again – alarm bells. It shows that we are entering into a world where more and more common infections become difficult – or even sometimes impossible – to treat. However, ambitious national policies in some countries limiting antimicrobial use have led to a decrease of antimicrobial resistance.

“So before the alarm bells become a deafening siren, let’s make sure that we increasingly act all together, in every country and across the public health, animal health and environment sectors under the One Health approach umbrella.”

[supersonico] 11/3/2019 12:09

Divergence;

Shoppers Want More Sustainable Products, But Brands Are Struggling To Keep Up


……………

Chlorinated Chicken..That's just the start of taking back control by instead handing control of poisoning ourselves to the Cartel of Global extinction practitioners.



Brexit Comfort;

The Senate voted to confirm former coal lobbyist Andrew Wheeler as official head of the U.S. Environmental Protection Agency (EPA) Thursday.

[supersonico] 11/3/2019 11:57

Keele professor secures full Government inquiry into food security



Professor Bruce said: “I am delighted that ‘My Science Inquiry’ is being taken forward to a full inquiry and look forward to working with the Commons Science and Technology Committee. There is an urgent need for increased research and innovation to help improve food security and protect the environment. I hope that the forthcoming inquiry will be a catalyst for change and will help to address some serious limitations that currently impede our innovation system, particularly with respect to providing new options for protecting harvests from pests”.

During the presentation of his research, Professor Bruce said: “The choice we have at the moment is having to choose between food security and the environment, so we need to find a way forward in which we can safeguard our crops without environmental impact, partly through smarter regulation to bring more inventions into the market. There is a critical shortage of new treatments but there’s also underinvestment in this area. It's a major challenge that we face this century, how do we feed the world without wrecking the environment in the process.”

[supersonico] 11/3/2019 08:46

The Eden Timeline:)

[brucie5] 11/3/2019 07:24

What sort of timeline are you guys thinking for a material decision on Sustaine?

[supersonico] 10/3/2019 08:08

Eden should have sent the details over in Mandarin then the Xinhua News Agency would have had less opportunity to screw up the translation.

[paulpaolo] 10/3/2019 00:18

I am feeling more annoyed on reflection that the evening standard piece described Eden's mevalone as another nematicide and hence a competitor to Eden's cedroz. A lot of aim shares I invest in are binary bets on whether or not an area has high grade lithium, or gold, or extractable oil. Eden has so many angles, Mevalone, cedroz which will be the biggest earner, the nit treatment in September in UK if terpentech doesn't delay any more (I no longer trust TT entirely), the bio deodorant, and licensing in multiple countries including mevalone in california, very soon the nit treatment in usa, etc. Saying that cedroz and mevalone are competitors when they are not, is a daft mistake as mevalone is their current earner and a wet or at least not dry EU summer could be great for earnings here, and Cedroz will soon be their biggest earner (I believe). Not competitors. Grrr. Nano is another firm that has a lot of patents so is the nearest in AIM to eden, but unlike eden, nano has no product sales yet and not for at least a year. I now prefer eden to nano, but not nearly so happy with terpentech as eden partner, as eastman who have just been superb.

[supersonico] 07/3/2019 22:35

carey gillam @careygillam

'Judge in Roundup cancer trial rules on Monsanto motion to end trial, saying "Monsanto cannot prevail on a motion for summary judgment by simply ignoring large swaths of evidence." He says evidence shows Monsanto doesn't care if its product causes cancer'.

And this also from Chhabria: "The plaintiffs have presented a great deal of evidence that Monsanto @Bayer has not taken a responsible, objective approach to the safety of its product."

'For similar reasons, the plaintiffs presented sufficient evidence at summary judgment to
support a punitive damages award against Monsanto. Although the evidence that Roundup causes
cancer is quite equivocal, there is strong evidence from which a jury could conclude that
Monsanto does not particularly care whether its product is in fact giving people cancer, focusing
instead on manipulating public opinion and undermining anyone who raises genuine and
legitimate concerns about the issue'.